4
Changes in Ownership
Evommune, Inc. Filed Acc 0002092017-25-000005
Options or other derivatives
- Chief Scientific Officer acquired 179,619 shares (grant or award)
From the SEC's structured data for this filing
Evommune, Inc. Filed Acc 0002092017-25-000005
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…